Abstract
N',N"'-[2,2'-[[1,1'-Biphenyl]-4,4'-diylbis(oxy)]bis(acetyl)]di(benzohydrazide) 3 was prepared by reaction of 2,2'-[1,1'-biphenyl]-4,4'-diylbis(oxy)]bisacetohydrazide 2 with benzoyl chloride. A new series of the arylidene 4-15 was prepared by heating 2 with the following aldehydes: 4-flourobenzaldehyde, p-tolualdehyde, 2-hydroxy-3- methoxybenzaldehyde, 2-chlorobenzaldehyde, isonicotinaldehyde (4-pyridine carboxaldehyde), benzaldehyde, 4- chlorobenzaldehyde, picolinaldehyde (2-pyridine carboxaldehyde), 4-methoxybenzaldehyde (4-anisaldehyde), 3- bromobenzaldehyde, 2,4,6-trimethoxybenzaldehyde and 4-hydroxy-3-methoxybenzaldehyde (vaniline). The compounds were evaluated against influenza virus. Two compounds showed moderate activity which means that with more derivatization, better activity could be expected.
Keywords: Aryloxyacetohydrazides, hydrazones, bisphenols, influenza virus.
Letters in Organic Chemistry
Title:Synthesis, Characterization and Biological Evaluation Against Influenza Virus Agonists of (N'E,N'"E)-2,2'-[[1,1'-Biphenyl]-4,4'-dihylbis(oxy)]bis (N'-arylmethyleneacetohydrazides)
Volume: 11 Issue: 3
Author(s): El Sayed H. El Ashry, Zia Ud Din, Zahid H. Soomro, Wajid Rahman, Muhammad Raza Shah, Yeldez El Kilany, Lieve Naesens and Ahmed T.A. Boraei
Affiliation:
Keywords: Aryloxyacetohydrazides, hydrazones, bisphenols, influenza virus.
Abstract: N',N"'-[2,2'-[[1,1'-Biphenyl]-4,4'-diylbis(oxy)]bis(acetyl)]di(benzohydrazide) 3 was prepared by reaction of 2,2'-[1,1'-biphenyl]-4,4'-diylbis(oxy)]bisacetohydrazide 2 with benzoyl chloride. A new series of the arylidene 4-15 was prepared by heating 2 with the following aldehydes: 4-flourobenzaldehyde, p-tolualdehyde, 2-hydroxy-3- methoxybenzaldehyde, 2-chlorobenzaldehyde, isonicotinaldehyde (4-pyridine carboxaldehyde), benzaldehyde, 4- chlorobenzaldehyde, picolinaldehyde (2-pyridine carboxaldehyde), 4-methoxybenzaldehyde (4-anisaldehyde), 3- bromobenzaldehyde, 2,4,6-trimethoxybenzaldehyde and 4-hydroxy-3-methoxybenzaldehyde (vaniline). The compounds were evaluated against influenza virus. Two compounds showed moderate activity which means that with more derivatization, better activity could be expected.
Export Options
About this article
Cite this article as:
Ashry Sayed H. El El, Din Ud Zia, Soomro H. Zahid, Rahman Wajid, Shah Raza Muhammad, Kilany El Yeldez, Naesens Lieve and Boraei T.A. Ahmed, Synthesis, Characterization and Biological Evaluation Against Influenza Virus Agonists of (N'E,N'"E)-2,2'-[[1,1'-Biphenyl]-4,4'-dihylbis(oxy)]bis (N'-arylmethyleneacetohydrazides), Letters in Organic Chemistry 2014; 11 (3) . https://dx.doi.org/10.2174/1570178610666131118222358
DOI https://dx.doi.org/10.2174/1570178610666131118222358 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Abelson Tyrosine-Protein Kinase 1 as Principal Target for Drug Discovery Against Leukemias. Role of the Current Computer-Aided Drug Design Methodologies
Current Topics in Medicinal Chemistry Decaprenylphosphoryl-β-D-Ribose 2-Epimerase from Mycobacterium tuberculosis is a Magic Drug Target
Current Medicinal Chemistry Molecular Dissection of Renal Ischemia-Reperfusion: Oxidative Stress and Cellular Events
Current Medicinal Chemistry Computational Biology and Drug Discovery: From Single-Target to Network Drugs
Current Bioinformatics Premature Ageing Prevention: Limitations and Perspectives of Pharmacological Interventions
Current Drug Targets The Indian Pediatric HIV Epidemic: A Systematic Review
Current HIV Research Macrophage Targeted Cellular Carriers for Effective Delivery of Anti-Tubercular Drugs
Recent Patents on Anti-Infective Drug Discovery Subject Index to Volume 1
Current Pharmacogenomics MRSA Infections: From Classical Treatment to Suicide Drugs
Current Medicinal Chemistry S-Nitrosylation: Targets, Controls and Outcomes
Current Genomics Regulatory T Cells and Cancer Therapy: An Old Story with a New Hope
Current Cancer Therapy Reviews Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers
Current Pharmaceutical Design Development and Validation of a Liquid Chromatographic Method for Aroylhydrazones at Hydrolytic Conditions
Current Pharmaceutical Analysis Editorial [Revisiting the Paris Declaration: Pharmacogenomics and Personalized Medicine as Accelerators for Development Aid and Effectiveness]
Current Pharmacogenomics and Personalized Medicine Radical Releasing Anti-tuberculosis Agents and the Treatment of <i>Mycobacterial Tuberculosis</i> Infections - An Overview
Mini-Reviews in Medicinal Chemistry New Vaccines and Delivery Strategies for Adult Immunization
Current Immunology Reviews (Discontinued) Inter-Species/Host-Parasite Protein Interaction Predictions Reviewed
Current Bioinformatics Interplay between Catalysts and Substrates for Activity of Class Ib Aminoacyl-tRNA Synthetases and Implications for Pharmacology
Current Topics in Medicinal Chemistry Antitubercular and Antimicrobial Activity of NH4VO3 Promoted 1,4- Dihydropyridine Incorporated 1,3,4-trisubstituted Pyrazole
Letters in Drug Design & Discovery Review of QSAR for DNA Polymerase Inhibitors and New Models for Heterogeneous Series of Compounds
Current Computer-Aided Drug Design